ACLX NASDAQ
Arcellx, Inc.
1W: +0.0%
1M: +0.2%
3M: +68.6%
YTD: +81.7%
1Y: +77.8%
3Y: +180.7%
$115.07
Last traded 2026-05-15 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships5
As Filer
counterparties named
1
As Counterparty
mentioned by others
4
Rel. Types
2022-02-17
Earliest Filing
2026-02-23
Latest Filing
acquirer: 2
partner: 1
investor: 1
supplier: 1
Counterparties (Filed by ACLX)
5 relationshipsCompanies named in ACLX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | GILD | acquirer | Parent company acquiring Arcellx, Inc. in a two-step merger transaction. | 2026-02-23 | View |
| Ravens Sub, Inc. | — | acquirer | Wholly owned subsidiary of Gilead Sciences, Inc. acting as the Purchaser in the merger. | 2026-02-23 | View |
| Kite Pharma, Inc. | — | partner | Partner in collaboration and license agreement for ARC-SparX program | 2023-11-15 | View |
| Gilead Sciences, Inc. | GILD | investor | Investor purchasing common stock and partner in collaboration agreement | 2023-11-15 | View |
| Lonza Houston, Inc. | — | supplier | Manufacturing services agreement for development and cGMP manufacturing of CART-ddBCMA | 2022-02-17 | View |
Mentioned As Counterparty
1 mentionsOther companies that named ACLX in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-04-28 | Acquisition/Disposition; Delisting Notice; Change in Control; Officer/Director Change; Bylaws Amendm | Acquisition | View |
| 2026-02-23 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2025-12-08 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-28 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-14 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-20 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-12-12 | Other Events; Financial Statements and Exhibits | View | |
| 2024-12-09 | Other Events; Financial Statements and Exhibits | View | |
| 2024-11-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-05 | Other Events; Financial Statements and Exhibits | View | |
| 2024-08-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-05-29 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-05-09 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-03-14 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2024-02-28 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2023-12-12 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR